{
  "trial_id": "NCT00323882",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Race, Baseline PSA levels, Baseline testosterone levels, ECOG performance status, Prior radiation therapy, Bisphosphate therapy status, Presence of measurable disease, Bone scan results, Prior use of antiandrogen therapy, Prior use of herbal products affecting PSA levels, Prior use of corticosteroids, History of autoimmune disease, History of hypersensitivity reactions, Baseline pain assessment, Baseline use of narcotic analgesics.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Race"
        ],
        [
          "Mean Prostate-Specific Antigen (PSA) in ng/mL",
          "Baseline PSA levels"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment",
        "Male"
      ],
      "remaining_candidate_features": [
        "Baseline testosterone levels",
        "Prior radiation therapy",
        "Bisphosphate therapy status",
        "Presence of measurable disease",
        "Bone scan results",
        "Prior use of antiandrogen therapy",
        "Prior use of herbal products affecting PSA levels",
        "Prior use of corticosteroids",
        "History of autoimmune disease",
        "History of hypersensitivity reactions",
        "Baseline pain assessment",
        "Baseline use of narcotic analgesics"
      ]
    },
    "processed-gen-response": "Age, Gender, Race, Baseline PSA levels, Baseline testosterone levels, ECOG performance status, Prior radiation therapy, Bisphosphate therapy status, Presence of measurable disease, Bone scan results, Prior use of antiandrogen therapy, Prior use of herbal products affecting PSA levels, Prior use of corticosteroids, History of autoimmune disease, History of hypersensitivity reactions, Baseline pain assessment, Baseline use of narcotic analgesics."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline PSA levels, Testosterone levels, Bone scan results, Prior radiation therapy, Prior antiandrogen therapy, Use of bisphosphonates,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Mean Prostate-Specific Antigen (PSA) in ng/mL",
          "Baseline PSA levels"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)"
      ],
      "remaining_candidate_features": [
        "Testosterone levels",
        "Bone scan results",
        "Prior radiation therapy",
        "Prior antiandrogen therapy",
        "Use of bisphosphonates"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Race/Ethnicity, Region of Enrollment, Baseline PSA levels, Testosterone levels, Bone scan results, Prior radiation therapy, Prior antiandrogen therapy, Use of bisphosphonates"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Gleason Score, PSA at Screening, Hemoglobin at Screening, Lymph Node Status, Bone Scan Result, Prior Hormone Therapy, Prior Radiation Therapy, Prior Bisphosphonate Therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG Performance Status"
        ],
        [
          "Mean Prostate-Specific Antigen (PSA) in ng/mL",
          "PSA at Screening"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female"
      ],
      "remaining_candidate_features": [
        "Gleason Score",
        "Hemoglobin at Screening",
        "Lymph Node Status",
        "Bone Scan Result",
        "Prior Hormone Therapy",
        "Prior Radiation Therapy",
        "Prior Bisphosphonate Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Gleason Score, PSA at Screening, Hemoglobin at Screening, Lymph Node Status, Bone Scan Result, Prior Hormone Therapy, Prior Radiation Therapy, Prior Bisphosphonate Therapy."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, weight, height, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, prostate-specific antigen (PSA) level, testosterone level, Gleason score, number of metastatic sites, prior radiation therapy, prior hormone therapy, bisphosphate therapy, bone scan results, measurable disease status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ],
        [
          "Mean Prostate-Specific Antigen (PSA) in ng/mL",
          "prostate-specific antigen (PSA) level"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "testosterone level",
        "Gleason score",
        "number of metastatic sites",
        "prior radiation therapy",
        "prior hormone therapy",
        "bisphosphate therapy",
        "bone scan results",
        "measurable disease status"
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, weight, height, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, prostate-specific antigen (PSA) level, testosterone level, Gleason score, number of metastatic sites, prior radiation therapy, prior hormone therapy, bisphosphate therapy, bone scan results, measurable disease status."
  }
}